Orasis is an emerging ophthalmic pharmaceutical company with the goal of making near vision clear again. They are committed to the Ophthalmology and Optometry segments because they know that presbyopia is ubiquitous. By virtue of their first in class formulation, Orasis is well-positioned to be first-line therapy in this emerging category by addressing a significant unmet need for patients.

Pharmaceutical

Orasis Pharmaceuticals

Elad Kedar

Yaron Shimon

Merav Zeide

Ilan Rubin

Paul Smith

Iris Meisner

Ron Neumann

Sharon Amzel-Sasson

The Advisory and Board Team at Orasis Pharmaceuticals provides strategic guidance, governance, and expert advice to drive the company's mission of addressing presbyopia through innovative ophthalmic solutions. Comprised of seasoned board members and industry advisors, the team ensures that Orasis remains at the forefront of ophthalmology by leveraging their extensive experience and insights.

Advisory and Board Team

Leadership Team

Clinical and Medical Affairs

Advisory and Board Team

About

Team members

Other teams at Orasis Pharmaceuticals

Leadership Team

Clinical and Medical Affairs